key: cord-0759117-0haf57l1
authors: Lu, Dawei; Sang, Lin; Du, Shihua; Li, Tao; Chang, Yange; Yang, Xiu‐An
title: Asymptomatic COVID‐19 infection in late pregnancy indicated no vertical transmission
date: 2020-04-30
journal: J Med Virol
DOI: 10.1002/jmv.25927
sha: c8e5531534f238c7ace53cdfd6633559bd80fed4
doc_id: 759117
cord_uid: 0haf57l1

This study is to investigate the clinical characteristics of late pregnancy with asymptomatic 2019 novel coronavirus disease (COVID‐19) infection, evaluate the outcome of maternal and fetal prognosis, and identify the evidence of intrauterine vertical transmission. A 22‐years‐old pregnant woman with asymptomatic COVID‐19 infection who was admitted to our hospital on 11 February 2020 was enrolled in this study. Clinical data including laboratory test results and chest computed tomography (CT) scanning were collected and reviewed. Diagnosis of late pregnancy with asymptomatic COVID‐19 infection was made. Lumbar anesthesia for cesarean section was performed and a female baby was delivered uneventfully, with the Apgar score of 9 to 10 points. Three times of COVID‐19 nucleic acid test for the baby was negative after delivery. The puerpera returned to normal after the operation and two times of throat swab COVID‐19 nucleic acid test were all negative after antiviral therapy. We reported an asymptomatic COVID‐19 pregnant woman with detailed clinical information and our result indicated that for late pregnant women with asymptomatic COVID‐19 infection, there might be no intrauterine infection caused by vertical transmission.

the Apgar score of 9 to 10 points. Three times of COVID-19 nucleic acid test for the baby was negative after delivery. The puerpera returned to normal after the operation and two times of throat swab COVID-19 nucleic acid test were all negative after antiviral therapy. We reported an asymptomatic COVID-19 pregnant woman with detailed clinical information and our result indicated that for late pregnant women with asymptomatic COVID-19 infection, there might be no intrauterine infection caused by vertical transmission. shock, sepsis, and even death. 1, 2 The WHO has announced that the outbreak of COVID-19 pneumonia is a pandemic on 11 March 2020 (https://www.who.int/dg/speeches/detail/who-directorgeneral-s-opening-remarks-at-the-media-briefing-on-covid-19- 11-march-2020) . With the spread of COVID-19, pregnant women are at greater risk because they have a worse prognosis than nongraviditas lady once they got respiratory syndrome. 3, 4 As of 28 March 2020, a total of 38 cases of pregnant women were reported and it seems no evidence that COVID-19 undergoes intrauterine or transplacental transmission, however, further studies with a large sample size are needed to confirm this conclusion. [5] [6] [7] [8] [9] To the best of our knowledge, pregnant women with asymptomatic COVID-19 infection are rarely reported. Herein, we report the first pregnant patient from Anhui Province of China with asymptomatic COVID-19 infection. We aimed to analyze the clinical characteristics of a COVID-19 infected pregnant woman to provide clinical data for understanding the maternal and neonatal outcomes and evaluating the existence of vertical transmission. Besides, combined with the characteristics of the Obstetrics and Pediatrics Department, we intend to provide a theoretical basis for obstetrical Dawei Lu and Lin Sang contributed equally to this work. management issues including the mother and fetus monitoring, treatment plan, timing and mode of pregnancy termination, and neonatal care.

This study was approved by the ethics committee of The No. 2

People's Hospital of Hefei City Affiliated to Anhui Medical University and informed consent was obtained from the patient before the study. A 22-year-old G1P0 woman, who was enrolled in this study, was 38 weeks pregnant. Regular prenatal check-up during pregnancy was performed before admission and no abnormality was discovered.

COVID-19 pneumonia was confirmed in her husband and sister, therefore, routine inspection of COVID-19 nucleic acid using quantitative reverse-transcription polymerase chain reaction was performed with her throat swab on 7th February. A positive result was achieved on 10th February. As a result, she was admitted to our hospital on 11 February 2020. On admission, no clinical features of COVID-19 pneumonia like fever, fatigue, cough, sore throat, shortness of breath, and diarrhea were noted. 2 The fetal movement was normal, about five times/hour. Physical examination indicated a body temperature of 36.8°C, a pulse of 97 beats per minute, respiratory rate of 21 breaths per minute, blood pressure of 109/74mm Hg, and oxygen saturation of blood of 99%. As illustrated in Table S1 , although some indexes of blood routine examination were beyond the normal ranges, they had little clinical significance. Biochemical indexes on 12 February showed that: total protein, 48.6 g/L; albumin, 28.5 g/L; alanine aminotransferase, 12 U/L; aspartate aminotransferase, 13 U/L; and lactate dehydrogenase, 158 U/L, indicating hypoproteinemia (Table S2) The newborn was delivered 5 minutes after the operation started, with Apgar scores of 9 to 10 and a weight of 3470 g. After the umbilical cord was broken, she was quickly handed over to the nurse outside the operating room for cleaning. Amniotic fluid, umbilical cord, or placenta was not used for the COVID-19 nucleic acid test owing to the emergency operation, however, the COVID-19 nucleic acid test on nasopharyngeal swabs, oropharyngeal swabs, and blood was performed immediately after delivery. As shown in Table S3 , all the results were negative. The newborn was kept in a warm box in the isolation intensive care unit of the neonatal nursery. She was fed artificially without any contact with his mother after birth for 14 days. Nucleic acid test performed 24 hours after the first sampling was negative (Table S3) 

It is well documented that pneumonia in pregnant woman may have more adverse outcomes (spontaneous abortion, intrauterine growth retardation, premature birth, etc) and the mortality rate of pregnant women is as high as 25%, far higher than that of the general infected population. 10 In our case, amniotic fluid was clear and the placental tissue was complete. No intrauterine infection was found in the fetus after three times of virus nucleic acid test, and the outcome of her was good, which, was consistent with previously reported cases. 6, 7 Our study supported the idea that no evidence of intrauterine or transplacental transmission for COVID-19 exists, however, this conclusion has yet to be further validated due to the small sample size. 5 It should be pointed out that we did not detect the viral nucleic acid in amniotic fluid and placenta, which will be the focus of our further study.

The indication of pregnancy termination depends on gestational age, complications, and the intrauterine fetal condition but not COVID-19 infection. Due to the small number of cases, which mode of delivery is safer has not been determined, however, it is suggested to relax the indications of cesarean section. 11 For our patient, considering that vaginal delivery might lead to amniotic fluid pollution in the birth canal and increase the risk of neonatal infection, the multidisciplinary team of our hospital decided to carry out an emergency cesarean section. Similar to previous reports, 6, 7 no adverse prognosis in the puerpera and newborn was noted, suggesting that our preoperative evaluation was correct. 

The authors declare that there are no conflict of interests.

Xiu-An Yang http://orcid.org/0000-0002-3485-0172 F I G U R E 2 Detailed information about medication for our patient during admission. Note: *intrauterine injection

SARS-CoV-2, the virus that causes COVID-19: cytometry and the new challenge for global health

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome

Epidemiology, lung mechanics and outcomes of ARDS: a comparison between pregnant and nonpregnant subjects

An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

A case of 2019 novel coronavirus in a pregnant woman with preterm delivery

Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province

Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia

Pneumonia in pregnancy

Problems of COVID-19 in the delivery of pregnant women

SARS-CoV-2 viral load in upper respiratory specimens of infected patients

Asymptomatic COVID-19 infection in late pregnancy indicated no vertical transmission